We are live on ! Find out more
KRRO icon

Korro Bio

55 hedge funds and large institutions have $14.1M invested in Korro Bio in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 16 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more capital invested

Capital invested by funds: $13M → $14.1M (+$1.1M)

0.05% less ownership

Funds ownership: 0.5%0.45% (-0.05%)

5% less funds holding

Funds holding: 5855 (-3)

33% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 9

44% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 16

Holders
55
Holders Change
-3
Holders Change %
-5.17%
% of All Funds
0.95%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
9
Reduced
16
Closed
9
Calls
$563K
Puts
Net Calls
+$563K
Net Calls Change
+$8K

KRRO Hedge Fund Activity: Q3 2022 in Review

55 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q3 2022, worth a combined $14.1M — up 8.5% from $13M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of KRRO and 6 opened new positions — a net loss of 3 holders — while 16 trimmed existing stakes and 9 added.

The largest buyer was Wasatch Advisors, adding an estimated $176K. The largest seller was Renaissance Technologies, cutting an estimated $505K.

  • 55 institutional investors held Korro Bio (KRRO) as of Q3 2022, down from 58 in Q2 2022.
  • Funds reported $14.1M of Korro Bio stock for Q3 2022, up 8.5% quarter-over-quarter.
  • 6 funds opened new Korro Bio positions in Q3 2022 and 9 closed out, a net change of -3 holders.
  • The largest Korro Bio buyer in Q3 2022 was Wasatch Advisors, an estimated $176K added.
  • The largest Korro Bio seller in Q3 2022 was Renaissance Technologies, an estimated $505K sold.

Based on aggregated 13F filings for Q3 2022.